iHere are the most recent health care related regulatory developments as published in the New Jersey Register on January 7, 2019:
-
On January 7, 2019, at 51 N.J.R. 17(a), the Department of Human Services, Division Of Medical Assistance And Health Services, issued a proposed rule amending N.J.A.C. 10:66, Independent Clinic Services, addressing the payment methodology for covered services provided in an ambulatory surgical center (ASC). The proposed amendments memorialize the New Jersey Medicaid/NJ FamilyCare program’s compliance with Federal rules regarding ASC reimbursement at 42 CFR Part 416, Subpart F: “Coverage, Scope of ASC Services, and Prospective Payment System for ASC Services Furnished on or After January 1, 2008.”
-
On January 7, 2019, at 51 N.J.R. 28(a), the Department of Community Affairs, Division of Law and Public Safety, Board of Medical Examiners proposed rules to require licensed athletic trainers to complete one credit of continuing education in topics concerning prescription opioid drugs every biennial renewal period. These topics would have to include the risks and signs of opioid abuse, addiction, and diversion. The proposal would amend N.J.A.C. 13:35-10.21.
-
On January 7, 2019, at 51 N.J.R. 83(a), the Department of Health, Public Health Services Branch, Division of Family Services, Maternal and Child Health Service, Child and Adolescent Health Program, readopted N.J.A.C. 8:51A with amendments to address lead screening in children under the age of 6. The only Federal regulation governing lead screening applies to children enrolled in Medicaid, which requires children to be screened at 12 and 14 months, or between 36 and 72 months in the case of a child who has not been previously screened. The readopted rules are as protective as Federal recommendations regarding childhood lead screening. Accordingly, N.J.A.C. 8:51A would continue to govern lead screening for non-Medicaid enrolled children in New Jersey. The goal is to have all children undergo lead screening.
